Moneycontrol PRO

business

DIPP floats Cabinet note on 49% FDI in brownfield pharma

The move comes shortly after the department was unsuccessful in blocking the Mylan-Strides Arcolab deal, which it felt was not in interest of the health security of the nation. DIPP wants to block such deals in the future through the proposal .

first published: Nov 14, 2013 08:45 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347